KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Other Non Operating Income (2019 - 2025)

GoodRx Holdings' Other Non Operating Income history spans 5 years, with the latest figure at $694000.0 for Q2 2025.

  • For Q2 2025, Other Non Operating Income changed N/A year-over-year to $694000.0; the TTM value through Dec 2025 reached -$1.4 million, up 33.41%, while the annual FY2024 figure was -$2.1 million, N/A changed from the prior year.
  • Other Non Operating Income for Q2 2025 was $694000.0 at GoodRx Holdings, up from -$2.1 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $1.8 million in Q3 2023 and bottomed at -$2.1 million in Q3 2024.
  • The 3-year median for Other Non Operating Income is -$557000.0 (2023), against an average of -$345750.0.
  • The largest YoY upside for Other Non Operating Income was 214.88% in 2024 against a maximum downside of 214.88% in 2024.
  • A 3-year view of Other Non Operating Income shows it stood at $1.8 million in 2023, then tumbled by 214.88% to -$2.1 million in 2024, then soared by 133.41% to $694000.0 in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Other Non Operating Income are $694000.0 (Q2 2025), -$2.1 million (Q3 2024), and $1.8 million (Q3 2023).